Impact Factor
3.47
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.47
407 total citations
h5-index
35
h5 depth signal
Cited share
63.9%
85 of 133
Total citations
407
Citation footprint
Metric signal
4.60
External metric anchor
Self-citation
2.0%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
492
United States
103
China
46
Germany
22
France
15
Citing Fields of Research
Immunology
678
Allergies
68
Immunotherapy
60
Inflammatory Bowel Diseases & Infections
48
Auto-Inflammatory Disorders
40
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,582
Articles tracked across the journal lifetime
Indexed publication set
133
85 cited publications
Last 12 months
69
5.8 publications/month
Open access share
23.2%
16 OA publications in the last year
Leading citing country
Japan
492 citing publications
Leading citing field
Immunology
678 citing publications
Latest tracked publication
3 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1989-
v1n1, 1989-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Broad Categories
Allergy and Immunology
Immunology
MeSH Descriptors
Immunity
Immunity, Cellular
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/intimm/dxag052
Open DOI
Toll-like receptors 7 and 8 as therapeutic targets for human diseases
Toll-like receptor 7 (TLR7) and TLR8 respond to pathogen-derived single-stranded RNA (ssRNA), orchestrating innate immune defense responses upon infections. However, aberrant recognition of endogenous ssRNAs by these sensors can cause va...
02
DOI 10.1093/intimm/dxag041
Open DOI
In This Issue
03
DOI 10.1093/intimm/dxag051
Open DOI
Regulatory T cells exhibit differential therapeutic effects across tissues during chronic autoimmune inflammation
Current therapies for autoimmune diseases rely largely on nonspecific immunosuppression, which can lead to adverse effects such as malignancy and severe infections. Regulatory T cell (Treg)-based therapies have therefore attracted attent...
04
DOI 10.1093/intimm/dxag050
Open DOI
PTPN22 mediates delayed negative feedback of T cell activation by forming an inhibitory signaling complex
Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) is a cytosolic tyrosine phosphatase expressed in immune cells that negatively regulates T cell receptor (TCR) signaling and is implicated in autoimmune diseases through a common (...
05
DOI 10.1093/intimm/dxag049
Open DOI
Polymorphic tail of HLA-DQ leads to the heterogeneous interleukin-10 response of antigen-presenting cells
The cytoplasmic tails of human leukocyte antigen (HLA) molecules are heterogeneous and polymorphic in terms of length and amino acid sequences. We previously showed that Class II HLA molecules transmitted signals in antigen presentation,...
06
DOI 10.1093/intimm/dxag048
Open DOI
STK11 deficiency drives NSCLC immune resistance via ETNK2-mediated phosphoethanolamine accumulation
STK11/LKB1 mutations are critical drivers of primary resistance to immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC); however, the metabolic mechanisms by which STK11 deficiency remodels the tumor microenvironment...
07
DOI 10.1093/intimm/dxag033
Open DOI
In This Issue
08
DOI 10.1093/intimm/dxag045
Open DOI
BNT162b2 mRNA vaccination activates spike-reactive regulatory T cells in humans
Studies using mouse models of viral infection have shown that viral antigen-reactive regulatory T cells (Tregs) play multiple context-dependent roles, including attenuating the immune response against the pathogen and limiting inflammato...
09
DOI 10.1093/intimm/dxag046
Open DOI
Redefining long-lived plasma cells by timestamping: isotype- and tissue-specific logic of plasma cell longevity
Long-lived plasma cells have traditionally been viewed through the lens of bone marrow-resident IgG-secreting cells that maintain systemic serological memory. However, recent timestamping approaches and isotype-specific analyses have rev...
10
DOI 10.1093/intimm/dxag044
Open DOI
Bispecific antibodies: current advances and future perspectives
Bispecific antibodies (BsAbs) are emerging immunotherapeutics that simultaneously engage two distinct targets. This property provides unique mechanisms of action not achieved by conventional monoclonal antibodies, including cell–cell bri...
Bibliographical & Catalog Notes
Title from cover.
Also available online.
Vol. 1, no. 1 (1989)19911012 Notice not published Printed on acid-free paper